The annual ABS at BASO audit of screen detected breast cancers was undertaken to examine NHS Breast Screening Programme surgical activity and was designed to assess surgical performance by comparison of data with as many as possible of the surgical Quality Assurance standards recommended by the UK NHS Breast Screening Programme.
The number and invasive status of screen detected breast cancers
Non-operative diagnosis and use of diagnostic open biopsy
ABS at BASO Breast Audit Steering Group
Dr Gill Lawrence
Director of Breast Screening Quality Assurance
West Midlands Cancer Intelligence Unit
Public Health Building
The University of Birmingham
Birmingham B15 2TT